Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Monopar Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company developing treatments for Wilson disease and novel radiopharmaceuticals for oncology. The Company’s product candidates are ALXN1840, MNPR-101, MNPR-101-Zr, MNPR-101-Lu, and MNPR-101-Ac. The Company’s Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, oral medicine. Its radiopharmaceutical program consists of MNPR-101, a proprietary humanized monoclonal antibody that is being developed across multiple product candidates conjugated with different radioisotopes, for the treatment of advanced solid tumors. MNPR-101-Zr is the Company’s clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. MNPR-101-Lu is its clinical-stage radiotherapeutic comprised of MNPR-101 conjugated to lutetium-177. MNPR-101-Ac is late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225.
Find out what a historical investment in Monopar Therapeutics Inc would be worth today using our MNPR stock calculator.
Buying MNPR shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Monopar Therapeutics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in MNPR
What is the ticker symbol of Monopar Therapeutics Inc?
The ticker symbol for Monopar Therapeutics Inc is MNPR.
How much is one share of MNPR?
One share of MNPR is valued at $70.29 as of 20 November 2026.
What is the market capitalisation of Monopar Therapeutics Inc MNPR?
As of 20 November 2026 Monopar Therapeutics Inc has a market cap of $479.46M.
What is the 52-week high for Monopar Therapeutics Inc stock?
The Monopar Therapeutics Inc 52-week high stock price is $124.82.
What is the 52-week low for Monopar Therapeutics Inc stock?
The Monopar Therapeutics Inc 52-week low stock price is $50.07.
Can I buy MNPR shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MNPR shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MNPR on Stake
Buy MNPR from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of MNPR from only US$10 with fractional shares